FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
AS - Asia 1.293
EU - Europa 1.059
NA - Nord America 427
SA - Sud America 296
AF - Africa 22
Totale 3.097
Nazione #
RU - Federazione Russa 756
CN - Cina 405
US - Stati Uniti d'America 401
SG - Singapore 373
BR - Brasile 235
HK - Hong Kong 189
IT - Italia 120
KR - Corea 111
VN - Vietnam 82
DE - Germania 75
IN - India 63
AR - Argentina 31
JP - Giappone 27
FI - Finlandia 20
NL - Olanda 15
EC - Ecuador 14
MX - Messico 14
AT - Austria 12
GB - Regno Unito 11
BD - Bangladesh 10
ZA - Sudafrica 10
IE - Irlanda 9
IQ - Iraq 9
FR - Francia 8
PL - Polonia 8
ID - Indonesia 7
UA - Ucraina 7
CA - Canada 6
ES - Italia 4
MA - Marocco 4
PY - Paraguay 4
UZ - Uzbekistan 4
VE - Venezuela 4
EG - Egitto 3
IL - Israele 3
TR - Turchia 3
UY - Uruguay 3
CH - Svizzera 2
CL - Cile 2
CZ - Repubblica Ceca 2
GT - Guatemala 2
KE - Kenya 2
PE - Perù 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
GE - Georgia 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SE - Svezia 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.097
Città #
Moscow 234
Santa Clara 210
Hong Kong 189
Hefei 155
Singapore 114
Seoul 111
Bengaluru 59
Munich 40
Ho Chi Minh City 38
Beijing 25
Dallas 25
Naples 24
The Dalles 23
Ashburn 20
São Paulo 19
Nuremberg 16
Los Angeles 15
Hanoi 13
Milan 12
Rio de Janeiro 12
Amsterdam 10
Dublin 9
Falkenstein 9
Helsinki 9
Vitulazio 9
Brooklyn 8
Turku 8
Caserta 7
Belo Horizonte 6
Quito 6
Boardman 5
Brasília 5
Curitiba 5
Formosa 5
Mexico City 5
Vienna 5
Warsaw 5
Angri 4
Florence 4
Guarulhos 4
Haiphong 4
Johannesburg 4
New York 4
Poços de Caldas 4
Tashkent 4
Trentola-Ducenta 4
Verona 4
Asunción 3
Baghdad 3
Campinas 3
Fortaleza 3
Hải Dương 3
Lappeenranta 3
Quilmes 3
Ribeirão Preto 3
Santo André 3
Thái Bình 3
Tianjin 3
Torre del Greco 3
Alghero 2
Bari 2
Bauru 2
Biên Hòa 2
Brescia 2
Buenos Aires 2
Bắc Ninh 2
Cachoeiro de Itapemirim 2
Cairo 2
Caldas Novas 2
Camden 2
Campo Grande 2
Canoas 2
Caracas 2
Caxias do Sul 2
Chicago 2
Da Nang 2
Duhok 2
Eunápolis 2
Feira de Santana 2
Gravataí 2
Grays 2
Guangzhou 2
Guaratinguetá 2
Guatemala City 2
Hangzhou 2
Joinville 2
Kronberg 2
Laferrere 2
London 2
Lviv 2
Maceió 2
Maldonado 2
Manaus 2
Montreal 2
Nairobi 2
Ninh Bình 2
Palermo 2
Passo Fundo 2
Recife 2
Resistencia 2
Totale 1.628
Nome #
Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy 77
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 72
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis 70
Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough 65
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy 65
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 64
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 64
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 63
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 63
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 62
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 62
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 62
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis 61
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 61
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 61
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 60
Anticoagulation in atrial fibrillation. A large real-world update 56
From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy 56
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 56
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): A pilot study 54
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 52
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson–Fabry disease 51
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 51
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 51
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 50
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 50
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 49
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 49
Post-procedural fever after transcatheter aortic valve implantation: a retrospective single-centre study 49
Prognostic Value of Malnutrition, Frailty, and Physical Performance in Transthyretin Cardiac Amyloidosis: Insights From a Prospective Multicenter Cohort Study 48
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 48
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 47
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 47
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 47
Prognostic impact of right ventricular dysfunction in patients with severe aortic stenosis treated with trans-catheter aortic valve implantation 46
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 46
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 45
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 45
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 45
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 45
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 45
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 44
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 43
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 43
β-blockers: Their new life from hypertension to cancer and migraine 42
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 41
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 40
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes? 39
Progression and prognostic significance of electrocardiographic findings in patients with cardiac amyloidosis 39
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 39
PCSK9 Inhibitors “Fast Track” Use Versus “Stepwise” Lipid-Lowering Therapy in Patients with Acute Coronary Syndrome: A Retrospective Single-Center Study in a “Real-World” Population 39
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study 39
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis 39
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus 38
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry 37
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 36
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 36
Wild-type transthyretin cardiac amyloidosis: the need for a comprehensive geriatric assessment beyond age 35
Use of Smartphone-operated ECG for home ECG surveillance in COVID-19 patients 33
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 33
The American College of Cardology/American Heart Association Heart Failure Staging System Highlights Diagnostic Delay and Predicts Outcome in Transthyretin Cardiac Amyloidosis 31
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 29
Post-procedural fever after Transcatheter Aortic Valve Implantation (TAVI). A multi-centric study 27
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 27
Change in prevalence of ATTR variants in Italy: results from a national survey 20
Development of a smartphone-based app to support the differential diagnosis in patients with primary left ventricular hypertrophy 14
Response to correspondence on 'Change in prevalence of ATTR variants in Italy' 12
Ranolazine in patients with chronic coronary syndromes: real-world data provide new evidence on the antiarrhythmic properties of the drug 12
Totale 3.167
Categoria #
all - tutte 11.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20236 0 0 0 0 2 0 0 0 3 0 1 0
2023/2024137 0 0 4 1 2 0 1 29 9 15 33 43
2024/2025947 5 42 13 61 155 116 188 47 75 79 69 97
2025/20262.077 176 427 329 194 379 572 0 0 0 0 0 0
Totale 3.167